On December 28, 2015, Chirag Patel went back to H.A. College of Commerce in Ahmedabad. He met the principal and faculty, remembered his student days, and discussed how to help more students. Then came the paperwork. A memorandum of understanding would connect his old college with New Jersey City University, where he had also studied. The return visit had a practical consequence: students could follow an educational route resembling his own, with help paying the tuition.
It is a revealing place to begin the story of a company founder. No opening bell, no acquisition announcement, no photograph of someone looking thoughtfully across a factory floor. Just an alumnus revisiting a college and putting money behind the next group of students. Nostalgia, on this occasion, had an accounts department.
By then, Patel had already helped build Amneal Pharmaceuticals with his younger brother, Chintu. The brothers had won a national entrepreneurship award. Their business had expanded far beyond its New Jersey beginnings. Yet the Ahmedabad meeting supplies something the corporate milestones cannot: a clear view of what Patel did with one of the routes that had opened to him. He went back and helped make it available to others.
A family business with a technology detour
The Patel family moved from India to the United States in 1987. Their father, Kanu, had worked as an industrial pharmacist and regulatory inspector in India. His influence on the brothers was both professional and personal. The family’s account of its beginnings emphasizes work, honesty and the Gandhian ideas of truth and service. Those principles would later appear in the company’s own language about how to conduct business.
Chirag’s education crossed the same two worlds. He earned a commerce degree at H.A. College and a business administration degree at New Jersey City University. NJCU identifies him with its class of 1989. His formal background was in business. Before committing himself full-time to Amneal, he co-founded NextGen Technologies and Veriprise Wireless. The eventual pharmaceutical executive had already spent time starting technology businesses.
That detour matters. Family background explains why this industry was familiar; it does not explain away the work of financing and growing a company. Chirag brought experience in commerce and entrepreneurship. Chintu brought his own professional experience. Amneal began in Paterson, New Jersey, in 2002, and Chirag committed to it full-time in 2005. The family connection came with different skills around the table.
The early money was decidedly personal. The business began with $200,000 in self-funding. Credit cards and second mortgages helped keep it going before an investment from a family friend supplied outside capital. Those are intimate financial instruments for an enterprise that would eventually report results to public shareholders. A second mortgage gives the phrase “personal commitment” an address.
In 2011, the brothers received the Ernst & Young National Entrepreneur Of The Year Life Sciences Award. The recognition reflected a business already using acquisitions, reinvestment and manufacturing expansion to grow. It also captured a particular family arrangement: two brothers taking different experience into a shared enterprise. The award made that partnership public. The work of keeping it productive continued after the ceremony.
The founders get their desks back
A founder’s biography can become misleadingly smooth when every year is presented as another step upward. Patel’s includes a change of seat. Amneal combined with Impax Laboratories in 2018. Chirag and Chintu became co-chairmen of the combined company, with other executives running the business. It was a new corporate arrangement, with a public market watching the results.
On August 5, 2019, the brothers returned as co-chief executives. Chirag also became president. The announcement acknowledged pressure from competition and industry conditions. The assignment was to improve the business in front of them. A memory of the early days could explain their attachment to Amneal; it could not do the work of managing costs, cash and operations.
“We built this business from the ground up.”
Chirag and Chintu Patel, on their return in 2019
Chirag’s stated priorities included lowering costs to improve margins, strengthening cash flow and pursuing business development opportunities. These are less romantic than the story of two brothers starting out. They are also what makes the return interesting. He had to take responsibility for a company whose scale, ownership and obligations had changed considerably since the self-funded beginning.
The co-CEO arrangement survived that transition. Chirag remains President and Co-Chief Executive Officer alongside Chintu, while also serving as a director. The career contains both the work of starting a family enterprise and the continuing obligation to operate a public company. The two jobs share a name on the door. Their daily demands are rather different.
Two colleges, one open door
Patel’s college commitments give the biography a second set of milestones. In 2014, New Jersey City University selected him for its Alumnus of Distinction Award at its American Dream Gala, an event intended to raise scholarship money. The university also awarded him an honorary Doctor of Humane Letters. His connection to the institution extended beyond the credential he had earned there.
The December 2015 Ahmedabad visit made the connection between his two colleges tangible. The initial agreement provided tuition sponsorship for three students pursuing management postgraduate study at NJCU. Patel also discussed how to help students outside that agreement. The conversation reached beyond sending a small group overseas.
A later H.A. College brochure described a program offering five selected students a full tuition scholarship for an NJCU MBA. It also described Niswarth scholarships for postgraduate study within India. These were different routes through the same practical obstacle: the cost of continuing an education. A student did not have to leave India to fall within the scope of his support.
of Commerce
City University
Patel studied at both institutions. His support helped connect them through postgraduate tuition scholarships.
The college’s January 2023 self-study recorded 17 students pursuing postgraduate study in the United States through the Patel Scholarship. It also recorded 32 recipients of Niswarth support over its preceding five-year reporting period. Those are historical counts, belonging to that report. They give the college connection a human scale beside the much larger numbers in a corporate results announcement.
There is something unusually concrete about this form of giving. The donor knows the institution where the students begin. He also knows the institution some hope to attend. The distance between Ahmedabad and New Jersey already exists in his own biography. Funding tuition turns a personal connection into an arrangement other people can use.
The family grows beyond the company
In 2013, Chirag and his wife, Priti, established the Niswarth International Foundation. Education sits within its commitments to children. Priti is a co-founder, making this another part of Patel’s work organized through a family partnership. The corporate biography gives the brothers much of the attention. The foundation brings a different partnership into view.
Patel also serves as a managing trustee of New Jersey’s Liberty Science Center. His public commitments include industry service: in 2022, he chaired the board of the Association for Accessible Medicines. Across these roles, the institutions vary in purpose and audience. They add a civic and educational dimension to a career most often introduced by its executive title.
The father’s influence has remained explicit. In their message accompanying Amneal’s code of business conduct, the brothers connect their approach to Kanu’s teaching about honest work. They tell employees that pressure cannot justify deliberately breaking the code. A family lesson has been written into an expectation for people who never sat at the family table.
That move is worth noticing without treating it as proof that every decision will meet the ideal. A code sets an obligation. A scholarship sets a financial commitment. A trustee position carries responsibilities. Patel’s public biography becomes more substantial when these commitments are described as work to be done, with people and institutions attached.
Still building, still returning
The business continues to change. In August 2026, Amneal completed its acquisition of Kashiv BioSciences, a company in which Chirag and Chintu had invested. The transaction followed a relationship spanning more than a decade. It brought development and manufacturing capabilities together with Amneal’s commercial operations. An earlier investment relationship had become part of the company’s next operating chapter.
There is expansion on the factory side as well. In July 2026, Amneal announced that its planned approximately 75,000-square-foot Brookhaven, New York, manufacturing facility had been selected for an FDA pilot program. The project was described as creating skilled manufacturing jobs. For a founder whose early business relied on personal financing, the current decisions involve substantial physical infrastructure.
The financial scale is visible in the second quarter of 2026: Amneal reported $796 million in net revenue and $58 million in GAAP net income. Revenue was 10 percent higher than in the corresponding quarter a year earlier. These are company results produced by many people. They establish the size of the operation for which Patel and his brother now share executive responsibility.
Yet the college visit remains a useful way to see him. It puts the corporate career in proportion to a smaller, specific decision: returning to a familiar institution and helping students pay for what came next. His story has factories, board changes and transactions. It also has a meeting in Ahmedabad, memories of being a student, and an agreement that gave other students somewhere to go.